BioCentury | Feb 22, 2016
Company News

ThioLogics, Albumedix deal

...Albumedix and ThioLogics partnered exclusively to commercialize albumin-drug conjugates, which the companies say will have improved...
...delivery and pharmacokinetic properties. The partners will use Albumedix’s Veltis albumin-based drug delivery technology and ThioLogics’...
...subsidiary of Novozymes A/S (CSE:NZYM B, Bagsvaerd, Denmark). The partners declined to disclose financial terms. ThioLogics Ltd....
Items per page:
1 - 1 of 1
BioCentury | Feb 22, 2016
Company News

ThioLogics, Albumedix deal

...Albumedix and ThioLogics partnered exclusively to commercialize albumin-drug conjugates, which the companies say will have improved...
...delivery and pharmacokinetic properties. The partners will use Albumedix’s Veltis albumin-based drug delivery technology and ThioLogics’...
...subsidiary of Novozymes A/S (CSE:NZYM B, Bagsvaerd, Denmark). The partners declined to disclose financial terms. ThioLogics Ltd....
Items per page:
1 - 1 of 1